Wolverine Trading, LLC Editas Medicine, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$3.39 - $5.96 $29,154 - $51,256	-8,600 Reduced 25.67%	24,900 $84,000
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $9,340 - $14,560	-2,000 Reduced 5.63%	33,500 $156,000
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $223,554 - $352,026	-31,800 Reduced 47.25%	35,500 $263,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $125,625 - $223,311	20,100 Added 42.58%	67,300 $681,000
Q3 2023 Nov 15, 2023	SELL	$6.92 - $9.31 $47,056 - $63,308	-6,800 Reduced 12.59%	47,200 $368,000
Q2 2023 Aug 23, 2023	BUY	$6.36 - $11.47 $343,440 - $619,380	54,000 New	54,000 $444,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $63,232 - $100,396	-7,600 Reduced 11.93%	56,100 $498,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $132,544 - $211,678	10,900 Added 20.64%	63,700 $775,000
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $8,991 - $19,215	-900 Reduced 1.68%	52,800 $646,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $15,488 - $30,393	1,100 Added 2.09%	53,700 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $1.33 Million - $2.03 Million	-50,100 Reduced 48.78%	52,600 $1.46 Million
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $1.96 Million - $3.65 Million	50,000 Added 94.88%	102,700 $4.37 Million
Q2 2021 Aug 06, 2021	BUY	$31.29 - $56.64 $478,737 - $866,592	15,300 Added 40.91%	52,700 $2.43 Million
Q1 2021 May 14, 2021	SELL	$39.71 - $90.58 $1.55 Million - $3.54 Million	-39,100 Reduced 51.11%	37,400 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $2.07 Million - $6.45 Million	76,500 New	76,500 $5.85 Million
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $1.15 Million - $1.52 Million	-40,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.5 - $34.34 $79,550 - $147,662	4,300 Added 11.75%	40,900 $1.2 Million
Q1 2020 May 11, 2020	SELL	$14.88 - $32.78 $188,976 - $416,306	-12,700 Reduced 25.76%	36,600 $741,000
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $267,013 - $447,031	13,700 Added 38.48%	49,300 $1.45 Million
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $170,924 - $203,756	-7,600 Reduced 17.59%	35,600 $800,000
Q2 2019 Aug 20, 2019	SELL	$20.48 - $27.76 $337,920 - $458,040	-16,500 Reduced 27.64%	43,200 $1.07 Million
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $540,154 - $734,198	27,800 Added 87.15%	59,700 $1.46 Million
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $187,357 - $327,437	10,300 Added 47.69%	31,900 $661,000
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $597,240 - $829,224	21,600 New	21,600 $687,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$9.42 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.08 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$5.93 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.05 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$2.98 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account